Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury

2006 ◽  
Vol 291 (3) ◽  
pp. L307-L311 ◽  
Author(s):  
Lorraine B. Ware ◽  
Eric Camerer ◽  
Karen Welty-Wolf ◽  
Marcus J. Schultz ◽  
Michael A. Matthay

Substantial progress has been made in understanding the contribution of alterations in coagulation and fibrinolysis to the pathogenesis of acute lung injury (ALI). Findings from mouse, rat, baboon, and human studies indicate that alterations in coagulation and fibrinolysis may be of major pathogenetic importance in ALI and other inflammatory conditions in the lung including pneumonia, sepsis, and ventilator-induced lung injury. Therapies targeted at both activation of coagulation through the extrinsic coagulation cascade and modulation of coagulation through the protein C system have the potential to favorably impact clinical ALI/acute respiratory distress syndrome.

2002 ◽  
Vol 283 (4) ◽  
pp. L678-L682 ◽  
Author(s):  
Michael A. Matthay ◽  
Sunita Bhattacharya ◽  
Donald Gaver ◽  
Lorraine B. Ware ◽  
Lina H. K. Lim ◽  
...  

A lung-protective ventilator strategy significantly reduces mortality in patients with acute lung injury. Substantial progress has been made in understanding how mechanical stress can injure the lung, both in terms of alterations in barrier properties of the pulmonary endothelium and epithelium as well as in stimulating proinflammatory responses of macrophages and neutrophils.


2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Vipul J. Patel ◽  
Sreeja Biswas Roy ◽  
Hiren J. Mehta ◽  
Myungsoo Joo ◽  
Ruxana T. Sadikot

Introduction. Acute respiratory distress syndrome (ARDS) is a complex clinical syndrome characterized by acute inflammation, microvascular damage, and increased pulmonary vascular and epithelial permeability, frequently resulting in acute respiratory failure and death. Current best practice for ARDS involves “lung-protective ventilation,” which entails low tidal volumes and limiting the plateau pressures in mechanically ventilated patients. Although considerable progress has been made in understanding the pathogenesis of ARDS, little progress has been made in the development of specific therapies to combat injury and inflammation. Areas Covered. In recent years, several natural products have been studied in experimental models and have been shown to inhibit multiple inflammatory pathways associated with acute lung injury and ARDS at a molecular level. Because of the pleiotropic effects of these agents, many of them also activate antioxidant pathways through nuclear factor erythroid-related factor 2, thereby targeting multiple pathways. Several of these agents are prescribed for treatment of inflammatory conditions in the Asian subcontinent and have shown to be relatively safe. Expert Commentary. Here we review natural remedies shown to attenuate lung injury and inflammation in experimental models. Translational human studies in patients with ARDS may facilitate treatment of this devastating disease.


2009 ◽  
Vol 4 (3) ◽  
pp. 219-227 ◽  
Author(s):  
Alexander D Cornet ◽  
Geerten P van Nieuw Amerongen ◽  
Albertus Beishuizen ◽  
Marcus J Schultz ◽  
Armand RJ Girbes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document